These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 25107452)

  • 1. Phospholipid transfer protein in diabetes, metabolic syndrome and obesity.
    Qin S; Song G; Yu Y
    Cardiovasc Hematol Disord Drug Targets; 2014; 14(2):149-53. PubMed ID: 25107452
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Plasma lecithin:cholesterol acyltransferase and phospholipid transfer protein activity independently associate with nonalcoholic fatty liver disease.
    Nass KJ; van den Berg EH; Gruppen EG; Dullaart RPF
    Eur J Clin Invest; 2018 Sep; 48(9):e12988. PubMed ID: 29947103
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Plasma phospholipid transfer protein (PLTP): review of an emerging cardiometabolic risk factor.
    Tzotzas T; Desrumaux C; Lagrost L
    Obes Rev; 2009 Jul; 10(4):403-11. PubMed ID: 19413703
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Phospholipid transfer protein activity and incident type 2 diabetes mellitus.
    Abbasi A; Dallinga-Thie GM; Dullaart RP
    Clin Chim Acta; 2015 Jan; 439():38-41. PubMed ID: 25304745
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Phospholipid transfer protein (PLTP) deficiency attenuates high fat diet induced obesity and insulin resistance.
    Song G; Zong C; Shao M; Yu Y; Liu Q; Wang H; Qiu T; Jiao P; Guo Z; Lee P; Luo Y; Jiang XC; Qin S
    Biochim Biophys Acta Mol Cell Biol Lipids; 2019 Oct; 1864(10):1305-1313. PubMed ID: 31220615
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Paraoxonase-1 activity is positively related to phospholipid transfer protein activity in type 2 diabetes mellitus: Role of large HDL particles.
    Dullaart RPF; Gruppen EG; Dallinga-Thie GM
    Clin Biochem; 2016 Apr; 49(6):508-510. PubMed ID: 26656640
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Plasma phospholipid transfer protein activity is independently determined by obesity and insulin resistance in non-diabetic subjects.
    de Vries R; Kappelle PJ; Dallinga-Thie GM; Dullaart RP
    Atherosclerosis; 2011 Jul; 217(1):253-9. PubMed ID: 21481395
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Plasma phospholipid transfer protein activity is related to insulin resistance: impaired acute lowering by insulin in obese Type II diabetic patients.
    Riemens SC; van Tol A; Sluiter WJ; Dullaart RP
    Diabetologia; 1998 Aug; 41(8):929-34. PubMed ID: 9726595
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Reverse modulation of the HDL anionic peptide factor and phospholipid transfer protein activity in coronary artery disease and type 2 diabetes mellitus.
    Attia N; Domingo N; Lorec AM; Nakbi A; Hammami S; Ben Hamda K; Portugal H; Lairon D; Hammami M; Chanussot F
    Clin Biochem; 2009 Jun; 42(9):845-51. PubMed ID: 19135989
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The impact of phospholipid transfer protein (PLTP) on HDL metabolism.
    Huuskonen J; Olkkonen VM; Jauhiainen M; Ehnholm C
    Atherosclerosis; 2001 Apr; 155(2):269-81. PubMed ID: 11254896
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Type 2 diabetes mellitus interacts with obesity and common variations in PLTP to affect plasma phospholipid transfer protein activity.
    Dullaart RP; Vergeer M; de Vries R; Kappelle PJ; Dallinga-Thie GM
    J Intern Med; 2012 May; 271(5):490-8. PubMed ID: 21973210
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Elevated plasma phospholipid transfer protein activity is a determinant of carotid intima-media thickness in type 2 diabetes mellitus.
    de Vries R; Dallinga-Thie GM; Smit AJ; Wolffenbuttel BH; van Tol A; Dullaart RP
    Diabetologia; 2006 Feb; 49(2):398-404. PubMed ID: 16374627
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Human plasma phospholipid transfer protein activity is decreased by acute hyperglycaemia: studies without and with hyperinsulinaemia in Type 1 diabetes mellitus.
    Oomen PH; van Tol A; Hattori H; Smit AJ; Scheek LM; Dullaart RP
    Diabet Med; 2005 Jun; 22(6):768-74. PubMed ID: 15910630
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Elevated baseline plasma phospholipid protein (PLTP) levels are an independent predictor of long-term all-cause mortality in patients with diabetes mellitus and known or suspected coronary artery disease.
    Cavusoglu E; Marmur JD; Chhabra S; Hojjati MR; Yanamadala S; Chopra V; Eng C; Jiang XC
    Atherosclerosis; 2015 Apr; 239(2):503-8. PubMed ID: 25710294
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Phospholipid transfer protein activity is determined by type 2 diabetes mellitus and metabolic syndrome, and is positively associated with serum transaminases.
    Dullaart RP; de Vries R; Dallinga-Thie GM; Sluiter WJ; van Tol A
    Clin Endocrinol (Oxf); 2008 Mar; 68(3):375-81. PubMed ID: 17877759
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Plasma angiopoietin-like 4 is related to phospholipid transfer protein activity in diabetic and non-diabetic subjects: role of enhanced low grade inflammation.
    Gruppen EG; Kersten S; Dullaart RPF
    Lipids Health Dis; 2018 Mar; 17(1):60. PubMed ID: 29587751
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Plasma phospholipid transfer protein activity is inversely associated with betaine in diabetic and non-diabetic subjects.
    Dullaart RP; Garcia E; Jeyarajah E; Gruppen EG; Connelly MA
    Lipids Health Dis; 2016 Aug; 15(1):143. PubMed ID: 27581838
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Characterization of the ZDSD Rat: A Translational Model for the Study of Metabolic Syndrome and Type 2 Diabetes.
    Peterson RG; Jackson CV; Zimmerman K; de Winter W; Huebert N; Hansen MK
    J Diabetes Res; 2015; 2015():487816. PubMed ID: 25961053
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Plasma phospholipid transfer protein activity is lowered by 24-h insulin and acipimox administration: blunted response to insulin in type 2 diabetic patients.
    Riemens SC; van Tol A; Sluiter WJ; Dullaart RP
    Diabetes; 1999 Aug; 48(8):1631-7. PubMed ID: 10426383
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Insulin resistance: a genetic approach. Overview.
    Martínez Larrad MT; González Sánchez JL; Serrano Ríos M
    Nestle Nutr Workshop Ser Clin Perform Programme; 2002; 6():79-93; discussion 93-5. PubMed ID: 16969968
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.